Immunosuppressive activity of bovine seminal ribonuclease and its mode of action
Language English Country Netherlands Media print
Document type Journal Article, Research Support, U.S. Gov't, P.H.S.
Grant support
GM-44783
NIGMS NIH HHS - United States
PubMed
8877402
DOI
10.1016/s0171-2985(96)80045-3
PII: S0171-2985(96)80045-3
Knihovny.cz E-resources
- MeSH
- ADP-ribosyl Cyclase MeSH
- ADP-ribosyl Cyclase 1 MeSH
- Antigens, Differentiation, B-Lymphocyte drug effects MeSH
- Antigens, CD drug effects MeSH
- Antigens, Differentiation drug effects MeSH
- Fluorescence Polarization MeSH
- Immunosuppressive Agents pharmacology MeSH
- Humans MeSH
- Lymphocytes drug effects MeSH
- Membrane Glycoproteins MeSH
- N-Glycosyl Hydrolases drug effects MeSH
- Receptors, Interleukin-2 drug effects MeSH
- Receptors, Transferrin MeSH
- Ribonucleases immunology pharmacology MeSH
- Cattle MeSH
- Semen enzymology immunology MeSH
- Lymphocyte Culture Test, Mixed MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Cattle MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, U.S. Gov't, P.H.S. MeSH
- Names of Substances
- ADP-ribosyl Cyclase MeSH
- ADP-ribosyl Cyclase 1 MeSH
- Antigens, Differentiation, B-Lymphocyte MeSH
- Antigens, CD MeSH
- CD38 protein, human MeSH Browser
- CD71 antigen MeSH Browser
- Antigens, Differentiation MeSH
- Immunosuppressive Agents MeSH
- Membrane Glycoproteins MeSH
- N-Glycosyl Hydrolases MeSH
- Receptors, Interleukin-2 MeSH
- Receptors, Transferrin MeSH
- Ribonucleases MeSH
Two preparations of dimeric BS RNase-native and recombinant proteins caused identical immunosuppressive effects on MLC-stimulated human lymphocytes. The monomers of RNase A and BS RNase were ten times less active. The inhibitory effect on MLC-stimmulation was followed by 90% inhibition of cell-mediated lympholysis (CML) caused by BS RNase (10 micrograms/ml). This effect indicated that BS RNase suppressed the recognition phase of the cytotoxic reaction, resulting in inhibition of generation of cytotoxic effector cells. BS RNase exerted a similar effect on generation of cytotoxic LAK cells. Cytotoxic activity of LAK cells or CTLs against K562 target cells was abrogated only when BS RNase was added at the beginning of the sensitizing phase, but the cytotoxicity of effector cells in the destruction phase was not influenced. The effect of RNase A on the generation of cytotoxic cells was much less pronounced. To get more information about the site of action, the effect of BS RNase on early lymphocyte stimulation by PHA was investigated by using fluorescein cell probes. BS RNase (100 micrograms/ml) prevented a shift in fluorescein emission occurring within one hour of activation using fluorescein diacetate as a marker for changes in the cytoplasmic matrix. On the contrary, it did not block the shift in fluorescence emission when tested with diphenylhexatrien as a marker for changes in membrane fluidity. Furthermore the effect of BS RNase on expression of membrane antigens expressed on activated human lymphocytes was estimated. BS RNase significantly inhibited the expression of CD25, CD38 and CD71 antigens on PHA-, Con A- and MLC-stimulated human T and B lymphocytes. No substantial change in expression of these antigens was observed on IL-2-stimulated cells, but DNA synthesis was totally abrogated. These results indicate that the mode of action of BS RNase on activated T and B lymphocytes is based mainly on the suppressed expression of receptors for interleukin-2-alpha-chain and transferrin.
References provided by Crossref.org
Structure analysis of group I plant nucleases
Ribonucleases endowed with specific toxicity for spermatogenic layers